Research ArticleTOXICOLOGY
Cardioprotective Effects of a Novel Iron Chelator, Pyridoxal 2-Chlorobenzoyl Hydrazone, in the Rabbit Model of Daunorubicin-Induced Cardiotoxicity
Martin Štěrba, Olga Popelová, Tomáš Šimůnek, Yvona Mazurová, Anna Potáčová, Michaela Adamcová, Helena Kaiserová, Přemysl Poňka and Vladimír Geršl
Journal of Pharmacology and Experimental Therapeutics December 2006, 319 (3) 1336-1347; DOI: https://doi.org/10.1124/jpet.106.111468
Martin Štěrba
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
Olga Popelová
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
Tomáš Šimůnek
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
Yvona Mazurová
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
Anna Potáčová
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
Michaela Adamcová
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
Helena Kaiserová
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
Přemysl Poňka
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
Vladimír Geršl
Department of Pharmacology (M.Š., O.P., V.G.), Department of Histology and Embryology (Y.M.), and Department of Physiology (A.P., M.A.), Faculty of Medicine in Hradec Králové and Department of Biochemical Sciences, Faculty of Pharmacy (T.Š., H.K.), Charles University in Prague, Hradec Králové, Czech Republic; and Lady Davis Institute for Medical Research, Departments of Physiology and Medicine, McGill University, Montreal, Quebec, Canada (P.P.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleTOXICOLOGY
Cardioprotective Effects of a Novel Iron Chelator, Pyridoxal 2-Chlorobenzoyl Hydrazone, in the Rabbit Model of Daunorubicin-Induced Cardiotoxicity
Martin Štěrba, Olga Popelová, Tomáš Šimůnek, Yvona Mazurová, Anna Potáčová, Michaela Adamcová, Helena Kaiserová, Přemysl Poňka and Vladimír Geršl
Journal of Pharmacology and Experimental Therapeutics December 1, 2006, 319 (3) 1336-1347; DOI: https://doi.org/10.1124/jpet.106.111468
Research ArticleTOXICOLOGY
Cardioprotective Effects of a Novel Iron Chelator, Pyridoxal 2-Chlorobenzoyl Hydrazone, in the Rabbit Model of Daunorubicin-Induced Cardiotoxicity
Martin Štěrba, Olga Popelová, Tomáš Šimůnek, Yvona Mazurová, Anna Potáčová, Michaela Adamcová, Helena Kaiserová, Přemysl Poňka and Vladimír Geršl
Journal of Pharmacology and Experimental Therapeutics December 1, 2006, 319 (3) 1336-1347; DOI: https://doi.org/10.1124/jpet.106.111468
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement